Alport Syndrome Epidemiology Analysis, 2020-2034: Which Age Group is the Largest Contributor in Patients Affected with Alport Syndrome?
10. Dezember 2024 07:34 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Alport Syndrome: Epidemiology Forecast to 2034" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
Alport Syndrome Pipeline Insight 2024, Featuring Eloxx Pharmaceuticals, Chinook Therapeutic, River 3 Renal Corp., Travere Therapeutics and Reata Pharmaceuticals
11. April 2024 11:04 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Alport Syndrome - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.The "Alport Syndrome - Pipeline Insight, 2024," report...